Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) has been given a consensus rating of “Buy” by the thirteen research ...
Zacks Investment Research on MSN1d
Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should KnowThe most recent trading session ended with Viking Therapeutics, Inc. (VKTX) standing at $29.28, reflecting a +1.14% shift from the previouse trading day's closing. The stock's change was less than the ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Currently trading with a volume of 1,145,610, the VKTX's price is down by -1.23%, now at $28.0. RSI readings suggest the ...
Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech, attracted the market's attention thanks to excellent midstage clinical ...
DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the ...
Bullish option flow detected in Viking Therapeutics (VKTX) with 8,905 calls trading, 2x expected, and implied vol increasing over 15 points to ...
Shares of Viking Therapeutics (NASDAQ:VKTX) have plunged since my November 2024 update and since I removed the stock from our Growth Stock Forum's model portfolio. My stated reasons for removal ...
Viking Therapeutics (NASDAQ:VKTX) traded higher in the premarket on Tuesday after the company announced a multi-year production agreement with the contract manufacturer CordenPharma to support the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback